Propeptide of procollagen type I (PIP) and outcomes in decompensated heart failure
- 1 March 2007
- journal article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 18 (2) , 129-134
- https://doi.org/10.1016/j.ejim.2006.09.014
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosisHeart, 2004
- Treatment of Congestive Heart FailureHypertension, 2001
- Congestive Heart Failure: Fifty Years of ProgressCirculation, 2000
- Heart Failure Survival Among Older Adults in the United StatesArchives of internal medicine (1960), 1999
- Extracellular Matrix Remodeling in Heart FailureCirculation, 1997
- Trends in hospitalization and mortality for heart failure in Spain, 1980-1993European Heart Journal, 1997
- Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathyHeart, 1997
- Collagen Scar Formation After Acute Myocardial InfarctionCirculation, 1997
- Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosisThe American Journal of Cardiology, 1995
- Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.Circulation, 1990